The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
Abstract
The phenomenon of enhanced glycolysis in tumours has been acknowledged for decades, but biochemical evidence to explain it is only just beginning to emerge. A significant hint as to the triggers and advantages of enhanced glycolysis in tumours was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tumour suppressors and which associated, for the first time, mitochondrial enzymes and their dysfunction with tumorigenesis. Further steps forward showed that the substrates of SDH and FH, succinate and fumarate, respectively, can mediate a 'metabolic signalling' pathway. Succinate or fumarate, which accumulate in mitochondria owing to the inactivation of SDH or FH, leak out to the cytosol, where they inhibit a family of prolyl hydroxylase enzymes (PHDs). Depending on the PHD inhibited, two newly recognized pathways that support tumour maintenance may ensue: affected cells become resistant to certain apoptotic signals and/or activate a pseudohypoxic response that enhances glycolysis and is conveyed by hypoxia-inducible factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In animal models, fumarate hydratase inactivation induces a precancerous phenotype associated with chronic HIF pathway activation, highlighting the intersection of mitochondrial metabolism, redox homeostasis, and HIF regulation [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“These metabolic perturbations, which are tightly linked to altered cellular redox balance, result in pseudohypoxic signaling and increased cancer susceptibility [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“Mitochondrial dysfunction could impair oxidative phosphorylation, the TCA cycle, fatty acid oxidation, the urea cycle, gluconeogenesis, and apoptotic pathways (King et al., 2006; Modica-Napolitano and Singh, 2004).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as King et al., 2006
In the citing paper
“Loss-of-function mutations in SDH and FH cause a build-up of succinate and fumarate, respectively87. Accordingly, increased levels of succinate and fumarate caused by mutations in these genes can compete with αKG and inhibit activity of HIF hydroxylases and thus induce normoxic HIF1α activity in vitro88,89.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [87]
In the citing paper
“Interestingly, inherited mutations in fumarate hydratase, another Krebs cycle enzyme, have also been linked to a separate and equally rare inherited cancer syndrome 96 .”
From The common biology of cancer and ageing (2007) · cites this paper as [96]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 4×
“Although both molecules were shown to mediate HIF induction (Isaacs et al., 2005; Selak et al., 2005), it is possible that they inhibit different PHDs with different efficiency.”
BackgroundInfluentialSelf-citationOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Moreover, enhanced glucose breakdown provides building blocks for the synthesis of nucleotides (via the pentose phosphate pathway), and amino and fatty acids (from glycolytic and TCA cycle intermediates) (Figure 1) (Owen et al., 2002).”
BackgroundOncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 1×
“These are reactive oxygen species (ROS), which can be generated by the ETC, especially in complex I and III (Raha and Robinson, 2000).”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K. (2004) · Nature Genetics · doi:10.1038/ng1494 · Cited by 980
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 674
Phaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 73
Southam, A. D., Easton, J. M., Stentiford, G. D., Ludwig, C., Arvanitis, T. N., & Viant, M. R. (2008) · Journal of Proteome Research · doi:10.1021/pr800353t · Cited by 75
Røsland, G. V., Dyrstad, S. E., Tusubira, D., Helwa, R., Tan, T. Z., Lotsberg, M. L., Pettersen, I. K. N., Berg, A., Kindt, C. K., Hoel, F., et al. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0197-8 · Cited by 69
Acetoacetate Accelerates Muscle Regeneration and Ameliorates Muscular Dystrophy in Mice
Zou, X., Meng, J., Li, L., Han, W., Li, C., Zhong, R., Miao, X., Cai, J. C., Zhang, Y., & Zhu, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.676510 · Cited by 70
Lee, W. D., Mukha, D., Aizenshtein, E., & Shlomi, T. (2019) · Nature Communications · doi:10.1038/s41467-019-09352-1 · Cited by 70
Li, L., & Tian, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114504 · Cited by 75
Kim, W. B., & Liau, L. M. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.04.009 · Cited by 71
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2
Borodovsky, A., Seltzer, M. J., & Riggins, G. J. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834d816a · Cited by 71
Belinsky, M. G., Rink, L. A., Flieder, D. B., Jahromi, M. S., Schiffman, J. D., Godwin, A. K., & von Mehren, M. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22023 · Cited by 69
Integrative metabonomics as potential method for diagnosis of thyroid malignancy
Tian, Y., Nie, X., Xu, S., Li, Y., Huang, T., Tang, H., & Wang, Y. (2015) · Scientific Reports · doi:10.1038/srep14869 · Cited by 68
Colen, R. R., Vangel, M. G., Wang, J., Gutman, D. A., Hwang, S. N., Wintermark, M., Jain, R., Nicolas‐Jilwan, M., Chen, J. Y., Raghavan, P., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-30 · Cited by 69
Prasad, S. B., & Verma, A. K. (2013) · Microscopy and Microanalysis · doi:10.1017/s143192761301324x · Cited by 68
Iommarini, L., Calvaruso, M. A., Kurelac, I., Gasparre, G., & Porcelli, A. M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.016 · Cited by 70
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 69
Wang, Y., Duan, Y., & Zhou, M. (2014) · Plant Pathology · doi:10.1111/ppa.12246 · Cited by 66
IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip
Frezza, C., Tennant, D. A., & Gottlieb, E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.031 · Cited by 66
Self-citationOxygen sensing and hypoxia-induced responses
Coleman, M. L., & Ratcliffe, P. J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430001 · Cited by 63
Paglia, G., Sigurjónsson, Ó. E., Rolfsson, Ó., Valgeirsdóttir, S., Hansen, M. B., Brynjólfsson, S., Guðmundsson, S., & Palsson, B. Ø. (2014) · Transfusion · doi:10.1111/trf.12710 · Cited by 67
Cancer cell metabolism: Rewiring the mitochondrial hub
Oliveira, G. L., Coelho, A. R., Marques, R., & Oliveira, P. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166016 · Cited by 65
Dual mode action of mangiferin in mouse liver under high fat diet
Lim, J., Liu, Z., Apontes, P., Feng, D., Pessin, J. E., Sauve, A. A., Angeletti, R. H., & Chi, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090137 · Cited by 64
Metabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 63
Mitochondrial uncoupling in cancer cells: Liabilities and opportunities
Baffy, G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.005 · Cited by 64
Lima, A. R., Pinto, J., Amaro, F., Bastos, M. D. L., Carvalho, M. C., & de Pinho, P. G. (2021) · Metabolites · doi:10.3390/metabo11030181 · Cited by 62
Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
Amoêdo, N. D., Rodrigues, M. F., Pezzuto, P., Galina, A., da Costa, R. M., Almeida, F. C. L., El‐Bacha, T., & Rumjanek, F. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022264 · Cited by 68
RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA
Gimenez‐Roqueplo, A., Burnichon, N., Amar, L., Favier, J., Jeunemaı̂tre, X., & Plouin, P. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04881.x · Cited by 62
Reporter Ligand NMR Screening Method for 2-Oxoglutarate Oxygenase Inhibitors
Leung, I. K. H., Demetriades, M., Hardy, A., Lejeune, C., Smart, T. J., Szöllössi, A., Kawamura, A., Schofield, C. J., & Claridge, T. D. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301583m · Cited by 62
Mitochondrial Dysfunction Impairs Tumor Suppressor p53 Expression/Function
Compton, S. L., Kim, C. G., Griner, N. B., Potluri, P., Scheffler, I. E., Sen, S., Jerry, D. J., Schneider, S. S., & Yadava, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163063 · Cited by 62
Fuhrmann, D. C., Wittig, I., & Brüne, B. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.007 · Cited by 61
Cyr, A. R., Hitchler, M. J., & Domann, F. E. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4850 · Cited by 62
IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?
Labussière, M., Sanson, M., Idbaïh, A., & Delattre, J. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0218 · Cited by 63
Matschke, J., Riffkin, H., Klein, D., Handrick, R., Lüdemann, L., Metzen, E., Shlomi, T., Stuschke, M., & Jendrossek, V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6589 · Cited by 63
The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
Tanabe, A., & Sahara, H. (2020) · Cancers · doi:10.3390/cancers12102780 · Cited by 61
Cell line-directed breast cancer research based on glucose metabolism status
Farhadi, P., Yarani, R., Valipour, E., Kiani, S., Hoseinkhani, Z., & Mansouri, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112526 · Cited by 60
MDH2 produced OAA is a metabolic switch rewiring the fuelling of respiratory chain and TCA cycle
Molinié, T., Cougouilles, E., David, C., Cahoreau, E., Portais, J., & Mourier, A. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148532 · Cited by 60
Степанова, А., Shurubor, Y. I., Valsecchi, F., Manfredi, G., & Galkin, A. S. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.06.002 · Cited by 58
Si, R.-W., Zhai, D.-D., Liao, Z.-H., Gao, L., & Yong, Y. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.12.035 · Cited by 58
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
Cuyàs, E., Fernández‐Arroyo, S., Corominas-Faja, B., Rodríguez‐Gallego, E., Bosch‐Barrera, J., Martı́n-Castillo, B., Llorens, R., Joven, J., & Menéndez, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3733 · Cited by 60
Enhanced tumorigenicity by mitochondrial DNA mild mutations
Cruz‐Bermúdez, A., Vallejo, C. G., Vicente-Blanco, R. J., Gallardo, M. E., Fernández‐Moreno, M. Á., Quintanilla, M., & Garesse, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3698 · Cited by 59
Mitochondrial biology in cancer stem cells
Loureiro, R., Mesquita, K. A., Novais, S. M., Oliveira, P. J., & Vega‐Naredo, I. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.012 · Cited by 63
Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
Le, A., Rajeshkumar, N. V., Maitra, A., & Dang, C. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0041 · Cited by 57
Locke, M., Ghazaly, E. A., Freitas, M. O., Mitsinga, M., Lattanzio, L., Nigro, C. L., Nagano, A., Wang, J., Chelala, C., Szlosarek, P. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.097 · Cited by 57
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
van Niekerk, G., & Engelbrecht, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0383-7 · Cited by 60
Chlorogenic Acid: The Conceivable Chemosensitizer Leading to Cancer Growth Suppression
Lukitasari, M., Nugroho, D. A., & Widodo, N. (2018) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x18789628 · Cited by 59
Cellular effects and clinical implications of SLC2A3 copy number variation
Ziegler, G. C., Álmos, P. Z., McNeill, R. V., Jansch, C., & Lesch, K. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29753 · Cited by 57
Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
Foo, B. J.-A., Eu, J. Q., Hirpara, J. L., & Pervaiz, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1341604 · Cited by 56
Wentzel, J. F., Lewies, A., Bronkhorst, A. J., van Dyk, E., Plessis, D., & Pretorius, P. J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.01.004 · Cited by 55
Metabolomic analysis for combined hepatotoxicity of chlorpyrifos and cadmium in rats
Xu, M., Wang, P., Sun, Y., & Wu, Y. (2017) · Toxicology · doi:10.1016/j.tox.2017.04.008 · Cited by 56
The mitochondrial bioenergetic capacity of carcinomas
Formentini, L., Martínez‐Reyes, I., & Cuezva, J. M. (2010) · IUBMB Life · doi:10.1002/iub.352 · Cited by 55
Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma
Grassian, A. R., Pagliarini, R. A., & Chiang, D. Y. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000050 · Cited by 54
Structural basis for malfunction in complex II
Iverson, T. M., Maklashina, E., & Cecchini, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.408419 · Cited by 53
Gaster, M., Nehlin, J. O., & Minet, A. D. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.656653 · Cited by 55
Diethylnitrosamine-induced hepatocarcinogenesis in rats: possible chemoprevention by blueberries
Sadik, N. A. H., El‐Maraghy, S. A., & Ismail, M. F. (2008) · African Journal of Biochemistry Research · doi:10.5897/ajbr.9000075 · Cited by 52
20 years of histone lysine demethylases: From discovery to the clinic and beyond
Gray, Z. H., Honer, M. A., Ghatalia, P., Shi, Y., & Whetstine, J. R. (2025) · Cell · doi:10.1016/j.cell.2025.02.023 · Cited by 59
Liu, W., Chen, H., Wong, N. W., Haynes, W., Baker, C. M., & Wang, X. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.025 · Cited by 52
Auslander, N., Cunningham, C. E., Toosi, B. M., McEwen, E., Yizhak, K., Vizeacoumar, F. S., Parameswaran, S., Gonen, N., Freywald, T., Bhanumathy, K. K., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177739 · Cited by 51
Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma
Pistollato, F., Abbadi, S., Rampazzo, E., Viola, G., Puppa, A. D., Cavallini, L., Frasson, C., Persano, L., Panchision, D. M., & Basso, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.003 · Cited by 51
Succinate dehydrogenase expression in breast cancer
Kim, S., Kim, D. H., Jung, W.-H., & Koo, J. S. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-299 · Cited by 51
Villa-Cuesta, E., Holmbeck, M. A., & Rand, D. M. (2014) · Journal of Cell Science · doi:10.1242/jcs.142026 · Cited by 51
Hawkins, B. J., Levin, M. D., Doonan, P. J., Petrenko, N. B., Davis, C. W., Patel, V. V., & Madesh, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143164 · Cited by 50
Houston, M. A., Augenlicht, L. H., & Heerdt, B. G. (2011) · International Journal of Cell Biology · doi:10.1155/2011/978583 · Cited by 50
Yang, Z., Zhou, J., Wei, B., Cheng, Y., Zhang, L., & XiaoMin, Z. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210469 · Cited by 50
Familial pheochromocytomas and paragangliomas
King, K. S., & Pacák, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.032 · Cited by 51
Information Dynamics in Living Systems: Prokaryotes, Eukaryotes, and Cancer
Frieden, B. R., & Gatenby, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022085 · Cited by 49
Gu, C., Yang, H., Chang, K., Zhang, B., Xie, F., Ye, J., Chang, R., Qiu, X., Wang, Y., Qu, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.009 · Cited by 52
Jeyaraju, D. V., Cisbani, G., de Brito, O. M., Koonin, E. V., & Pellegrini, L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.110 · Cited by 48
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy
Gnocchi, D., Sabbà, C., Massimi, M., & Mazzocca, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043710 · Cited by 50
Serum and Urinary Metabonomic Study of Human Osteosarcoma
Zhang, Z., Qiu, Y., Hua, Y., Wang, Y., Chen, T., Zhao, A., Chi, Y., Li, P., Hu, S., Li, J., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100480r · Cited by 48
Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
Gupta, R., Webb-Myers, R., Flanagan, S., & Buckland, M. E. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200227 · Cited by 49
Pistollato, F., Rampazzo, E., Abbadi, S., Puppa, A. D., Scienza, R., D’Avella, D., Denaro, L., Kronnie, G. T., Panchision, D. M., & Basso, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006206 · Cited by 48
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 54
Glyphosate, pathways to modern diseases IV: cancer and related pathologies
Samsel, A., & Seneff, S. (2015) · Journal of Biological Physics and Chemistry · doi:10.4024/11sa15r.jbpc.15.03 · Cited by 54
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Hamidi, A. A., Taghehchian, N., Basirat, Z., Zangouei, A. S., & Moghbeli, M. (2022) · Biomarker Research · doi:10.1186/s40364-022-00382-4 · Cited by 48
Mandeville, H., Ng, Q. S., Daley, F. M., Barber, P. R., Pierce, G., Finch, J., Burke, M. M., Bell, A. G., Townsend, E. R., Kozarski, R., et al. (2012) · Radiology · doi:10.1148/radiol.12111505 · Cited by 47
Mitonuclear Interactions Mediate Transcriptional Responses to Hypoxia inDrosophila
Mossman, J. A., Tross, J. G., Jourjine, N. A., Li, N., Wu, Z. J., & Rand, D. M. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw246 · Cited by 50
Inhibition of proteasome reveals basal mitochondrial ubiquitination
Sulkshane, P., Duek, I., Ram, J., Thakur, A., Reis, N., Ziv, T., & Glickman, M. H. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103949 · Cited by 47
José, C., Melser, S., Bénard, G., & Rossignol, R. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 51
Stubbs, C. J., Loenarz, C., Mecinović, J., Yeoh, K. K., Hindley, N., Liénard, B. M. R., Sobott, F., Schofield, C. J., & Flashman, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900285r · Cited by 46
Genetics of primary macronodular adrenal hyperplasia
Fragoso, M. C. B. V., Alencar, G. A., Lerário, A. M., Bourdeau, I., Almeida, M. Q., Mendonca, B. B., & Lacroix, A. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0568 · Cited by 46
Sun, X., & Zhu, M. J. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700932 · Cited by 46
Badur, M. G., & Metallo, C. M. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.013 · Cited by 44
Imaging Genomics of Glioblastoma
Elbanan, M., Amer, A. M., Zinn, P. O., & Colen, R. R. (2014) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2014.09.010 · Cited by 45
ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate
Keenan, M. M., Liu, B., Tang, X., Wu, J., Cyr, D. D., Stevens, R. D., Ilkayeva, O., Huang, Z., Tollini, L. A., Murphy, S. K., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005599 · Cited by 43
Targeting metabolic pathways for head and neck cancers therapeutics
Yamamoto, M., Inohara, H., & Nakagawa, T. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9691-z · Cited by 44
Comparison of cytotoxicity of IQOS aerosols to smoke from Marlboro Red and 3R4F reference cigarettes
Davis, B. A., To, V., & Talbot, P. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104652 · Cited by 44
Multifaceted Actions of Succinate as a Signaling Transmitter Vary with Its Cellular Locations
Guo, Y., Cho, S. W., Saxena, D. B., & Li, X. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.1.36 · Cited by 44
The power of yeast to model diseases of the powerhouse of the cell
Claypool, S. M. (2012) · Frontiers in bioscience · doi:10.2741/4098 · Cited by 42
GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice
Rubic-Schneider, T., Carballido‐Perrig, N., Regairaz, C., Raad, L., Jost, S., Rauld, C., Christen, B., Wieczorek, G., Kreutzer, R., Dawson, J., et al. (2016) · Allergy · doi:10.1111/all.13005 · Cited by 43
Rubas, N. C., Torres, A., & Maunakea, A. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178658 · Cited by 46
Kaipparettu, B. A., Ma, Y., & Wong, L. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05621.x · Cited by 41
Tang, J., Hu, J., Xue, M., Guo, Z., Xie, M., Zhang, B., Zhou, Z., Huang, W., & Hou, S. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0345-8 · Cited by 43
Role of coenzymes in cancer metabolism
Thapa, M., & Dallmann, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.027 · Cited by 45
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
Lulli, M., Coco, L. D., Mello, T., Sukowati, C. H. C., Madiai, S., Gragnani, L., Forte, P., Fanizzi, F. P., Mazzocca, A., Rombouts, K., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3134 · Cited by 41
Targeted therapy in SDH- deficient GIST
Nannini, M., Rizzo, A., Indio, V., Schipani, A., Astolfi, A., & Pantaleo, M. A. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211023278 · Cited by 41
Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma
Gooptu, M., Whitaker‐Menezes, D., Sprandio, J. D., Domingo‐Vidal, M., Lin, Z., Uppal, G. K., Gong, J. Z., Fratamico, R., Leiby, B. E., Dulau‐Florea, A., et al. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.10.002 · Cited by 40
Rodrı́guez, C., Puente‐Moncada, N., Reiter, R. J., Sánchez‐Sánchez, A. M., Herrera, F., Rodríguez‐Blanco, J., Duarte‐Olivenza, C., Turos‐Cabal, M., Antolı́n, I., & Martı́n, V. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29886 · Cited by 40
Energy metabolism as the target of 3-phenyllactic acid against Rhizopus oryzae
Fan, W., Li, B., Du, N., Hui, T., Cao, Y., Li, X., & Ren, H. (2022) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2022.109606 · Cited by 40
Joshi, A., Ito, T., Picard, D., & Neckers, L. (2022) · Biomolecules · doi:10.3390/biom12070880 · Cited by 40
Endogenous Hypoxia Markers: Case Not Proven!
Mayer, A., Höckel, M., & Vaupel, P. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-74911-2_15 · Cited by 40
Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression
Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 44
A metabolic perspective of Peto's paradox and cancer
Dang, C. V. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0223 · Cited by 39
Metadata
- Authors
- King, A., Selak, M. A., & Gottlieb, E.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Gottlieb, E
- Venue
- Oncogene
- Published
- 2006-08-07
- Volume
- 25
- Issue
- 34
- Pages
- 4675-4682
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2005828644
- Semantic Scholar
- 960f2f114b8beb17db8bd6d91cd79f788b80738a
- Cited by
- 672
- References
- 61
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 42 · 2021: 39 · 2020: 38 · 2019: 37 · 2018: 37 · 2017: 42 · 2016: 39 · 2015: 37 · 2014: 42 · 2013: 37 · 2012: 52
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- succinate dehydrogenase, fumarate hydratase, mitochondrial dysfunction, tumour suppressor, succinic acid, fumarate, metabolic signalling, prolyl hydroxylase inhibition, pseudohypoxia, hypoxia-inducible factor, apoptosis resistance, carcinogenesis
- MeSH terms
- Fumarate Hydratase, Humans, Mitochondria, Neoplasms, Succinate Dehydrogenase, Genes, Tumor Suppressor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
